Optimizing Medication Safety in Primary Care & Outpatient Settings: An Interactive Series 'High Risk Medication and Special Populations'

---

RSS

Monday, October 21, 2024, 4:00 PM - 5:30 PM, Online via Zoom

Date: October 21, 2024
Time: 4:00 PM - 5:30 PM

Speakers: Phyllis Muffuh Navti, DHSci, Anas Hamad, PhD, Ebtesam Abdulla, MSN, Palli Valapila Abdulrouf, PhD, Thabit Melhem, MSN

Objectives:

1. Outline High-Risk Medications
2. Discuss special considerations for pregnant and lactating Women
3. Discuss special consideration during fasting
4. Identify best practices in patient counselling to effectively communicate the importance of
adherence for antimicrobials and HIV medication to enhance treatment efficacy and reduce
resistance
5. Outline strategies to counsel patients on potential drug interactions and adverse drug reactions associated with high-risk medication

1. 1. Outline High-Risk Medications
2. 2. Discuss special considerations for pregnant and lactating Women
3. 3. Discuss special consideration during fasting
4. 4. Identify best practices in patient counselling to effectively communicate the importance of adherence for antimicrobials and HIV medication to enhance treatment efficacy and reduce resistance
5. 5. Outline strategies to counsel patients on potential drug interactions and adverse drug reactions associated with high-risk medication

QAR 25, USD 7 per session

The registration closes ONE day  before the activity. You will receive a UNIQUE  link to join the webinar on the day of the presentation.

Changes or Cancellations

• Name changes or substitutions are not permitted.
• All cancellation and refund requests must be made in writing and submitted via email to [email protected].
• For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
• We will attempt to process the refund within 30 days of receiving any cancellation request.
• Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to  [email protected].

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 1.5 hours.

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Mai Mahmoud, MD, Vyas Saseendran Kattezhathu, PhD, Ayat Kadhi, MSc, Andrew MacDonald, MSc, Ziana Vamanjoor, BDS

Have no relevant financial/non-financial relationships with any for-profit and not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products 

 

 Course Directors: Phyllis Muffuh Navti, DHSci, Anas Hamad, PhD

Have no relevant financial/non-financial relationships with any for-profit and not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Course Faculty: Phyllis Muffuh Navti, DHSci, Anas Hamad, PhD, Vyas Saseendran, PhD , Mai Mahmood, MD, Alla El-Awaisi, PhD, Andrew MacDonald, PhD, Reham Negmeldin, MD, Manal Al-Zaidan , PharmD, Ayat Kadhi, MSc, Ahmed Makhlouf, PhD, Ebtesam Abdullah, MSN, Palli Valapila Abdulrouf, PhD

Have no relevant financial/non-financial relationships with any for-profit and not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Course Faculty: Yasir Tarabichi, MD
Disclosed the following financial relationship:
Consulting fee, Beckman Coulter

All of the relevant financial/non-financial relationships with any for-profit and not-for-profit organizations have been mitigated
Will not be discussing unlabeled/unapproved use of drugs or products

Independant Content Reviewer (ICR): Phyllis Muffuh Navti, DHSci
Have no relevant financial/non-financial relationships with any for-profit and not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Administrative Contact: Ameena Abdul Rahim, MSc

Has no relevant financial/non-financial relationships with any for-profit and not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.